Chemophase FDA Approval Status
FDA Approved: No
Brand name: Chemophase
Generic name: recombinant human hyaluronidase
Company: Halozyme Therapeutics, Inc.
Treatment for: Chemoadjuvant
Chemophase is a novel recombinant investigational therapeutic being developed to enhance the delivery of chemotherapy.
Development Timeline for Chemophase
|Jun 30, 2005||Halozyme Therapeutics Announces Submission of Investigational New Drug Application|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.